This marker could help find heart attack patients most at risk

Alzheimer's has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain's energy supply help drive the disease, and restoring that balance can reverse damage, even in advanced cases.

A new study led by researchers at University College London (UCL) shows that chronic exposure to toxic air can significantly diminish the health benefits of regular physical activity.

Hypertension may impair the brain far earlier than previously understood -- even before a measurable rise in blood pressure occurs -- according to a new preclinical study from Weill Cornell Medicine. The changes help explain why hypertension is a major risk factor for developing cognitive disorders, such as vascular cognitive impairment and Alzheimer's disease.

Women who experience hypertensive disorders of pregnancy (HDP) face significantly higher risks of cardiovascular complications, including heart attack, stroke, heart failure, and death, within five years of giving birth, according to a new study by Intermountain Health researchers.

About 100,000 of the estimated million persons in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms worsening over time or following periods of remission.

Scientists discovered that tiny messengers released by fat tissue, called extracellular vesicles, can carry harmful signals that accelerate the buildup of amyloid-b plaques in the brain.

Cambridge scientists have created a breakthrough material that can sense tiny chemical changes in the body, such as the increased acidity during an arthritis flare-up, and release drugs exactly when and where they're needed.

Dr Dangs Lab has unveiled Dendrite Dx, an integrated ecosystem for early, non-invasive Alzheimer's diagnosis on 'World Alzheimer's Day.'

The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can lead to cirrhosis, liver failure, and even liver cancer.

Scientists from Finland and the UK have uncovered groundbreaking evidence that heart attacks may be triggered by infectious processes rather than just cholesterol and lifestyle factors.